Literature DB >> 59332

Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck.

R E Wittes, F Brescia, C W Young, G B Magill, R B Golbey, I H Krakoff.   

Abstract

28 patients with head and neck tumors not suitable for definitive treatment with radiation or surgery were treated with cis-diamminedichloroplatinum (II) and bleomycin in combination. Of 24 adequately treated patients, there were 3 partial remissions lasting for 3,3 and 6 months, respectively. Toxicity of the regimen as given was substantial; 13 patients showed some evidence of nephrotoxicity and there were 2 drug deaths related to progressive renal failure. 1 patient developed bleomycin pulmonary toxicity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 59332     DOI: 10.1159/000225069

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

1.  Update in cancer chemotherapy: head and neck cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-10       Impact factor: 1.798

2.  Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer.

Authors:  K Kolarić; A Roth
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Alteration and activation of sequence-specific cleavage of DNA by bleomycin in the presence of the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  P K Mascharak; Y Sugiura; J Kuwahara; T Suzuki; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  Protective effect of selenium on cisplatin induced nephrotoxicity: A double-blind controlled randomized clinical trial.

Authors:  Ali Ghorbani; Bita Omidvar; Abazar Parsi
Journal:  J Nephropathol       Date:  2013-04-01

5.  Secreted factors from bone marrow stromal cells upregulate IL-10 and reverse acute kidney injury.

Authors:  Jack M Milwid; Takaharu Ichimura; Matthew Li; Yunxin Jiao; Jungwoo Lee; Joshua S Yarmush; Biju Parekkadan; Arno W Tilles; Joseph V Bonventre; Martin L Yarmush
Journal:  Stem Cells Int       Date:  2012-12-19       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.